Literature DB >> 9308723

Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus.

M R Quddus1, J D Henley, R A Sulaiman, T C Palumbo, D R Gnepp.   

Abstract

Helicobacter pylori infection has been implicated in the development of chronic active gastritis and gastric neoplasms (ie, mucosa-associated lymphoid tumors and adenocarcinoma). The potential association between esophageal H pylori infection with Barrett's esophagus-associated adenocarcinoma has not been previously studied. Nineteen cases of adenocarcinoma arising in Barrett's esophagus were examined for the presence of H pylori. Barrett's esophagus was defined by the presence of metaplastic specialized-type epithelium (gastric-type epithelium with goblet cell metaplasia) in the distal esophagus. To detect the presence of H pylori, 5-microm sections, from several tissue blocks in each case, were stained with routine hematoxylin-eosin, modified Giemsa, and an antibody directed against H pylori (Dako a/s, Denmark, Lot # 111061). Stained sections were examined independently by two pathologists. All three staining methods failed to show H pylori in any of the cases examined. Sections of Barrett's esophagus (with and without dysplasia), adenocarcinoma, and stomach (when available) were uniformly negative for the presence of H pylori. We conclude that neither gastric nor esophageal infection with H pylori is a requisite for the development of adenocarcinoma in Barrett's esophagus. Moreover, it is unlikely that a significant association between H pylori infection and Barrett's-associated adenocarcinoma exists.

Entities:  

Mesh:

Year:  1997        PMID: 9308723     DOI: 10.1016/s0046-8177(97)90052-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Gastroesophageal reflux and Helicobacter pylori: a review.

Authors:  F Pace; G Bianchi Porro
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.

Authors:  M Kudo; O Gutierrez; H M T El-Zimaity; H Cardona; Z Z Nurgalieva; J Wu; D Y Graham
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  Helicobacter pylori and esophageal cancer risk: a meta-analysis.

Authors:  Farhad Islami; Farin Kamangar
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

4.  Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).

Authors:  Sri Ganeshamurthy Thrumurthy; Christopher John Lewis; Susan Pritchard; Gordon Armstrong; Stephen Edwin Arthur Attwood
Journal:  Surg Endosc       Date:  2012-01       Impact factor: 4.584

5.  Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus.

Authors:  V K Sharma; S E Demian; D Taillon; R Vasudeva; C W Howden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Authors:  A P Ireland; D K Shibata; P Chandrasoma; R V Lord; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

7.  Role of gastric acid secretion in the pathogenesis of Barrett's esophageal cancer in a Japanese population.

Authors:  Tomoyuki Koike; Shuichi Ohara; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2009-05-02

Review 8.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

9.  Barrett esophagus: perspectives on its diagnosis and management in asian populations.

Authors:  Yuji Amano; Yoshikazu Kinoshita
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.